A detailed history of Signaturefd, LLC transactions in Uni Qure N.V. stock. As of the latest transaction made, Signaturefd, LLC holds 208 shares of QURE stock, worth $1,335. This represents 0.0% of its overall portfolio holdings.

Number of Shares
208
Holding current value
$1,335
% of portfolio
0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$3.78 - $10.12 $786 - $2,104
208 New
208 $1,000
Q4 2023

Jan 31, 2024

BUY
$5.63 - $8.27 $11 - $16
2 Added 2.5%
82 $0
Q3 2023

Nov 03, 2023

BUY
$6.71 - $11.83 $536 - $946
80 New
80 $0
Q1 2023

Apr 28, 2023

SELL
$18.7 - $23.07 $2,244 - $2,768
-120 Reduced 72.29%
46 $0
Q4 2022

Jan 27, 2023

SELL
$18.12 - $27.32 $235 - $355
-13 Reduced 7.26%
166 $3,000
Q3 2022

Nov 08, 2022

BUY
$16.98 - $25.54 $3,039 - $4,571
179 New
179 $3,000
Q4 2021

Jan 25, 2022

SELL
$20.24 - $36.01 $425 - $756
-21 Closed
0 $0
Q3 2021

Oct 28, 2021

BUY
$26.01 - $38.22 $546 - $802
21 New
21 $1,000
Q1 2021

Apr 30, 2021

SELL
$29.24 - $42.03 $1,111 - $1,597
-38 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$35.35 - $50.67 $424 - $608
12 Added 46.15%
38 $1,000
Q3 2020

Nov 03, 2020

BUY
$35.98 - $47.66 $935 - $1,239
26 New
26 $1,000

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $300M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.